Cargando…
Hydroxychloroquine in IgA nephropathy: a systematic review
BACKGROUND: Hydroxychloroquine (HCQ) has recently been reported to be a promising and safe anti-proteinuric agent for IgA nephropathy (IgAN) patients. In the present systematic review, we aimed to summarize the evidence concerning the benefits and risks of HCQ therapy in IgAN. METHODS: Electronic da...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604447/ https://www.ncbi.nlm.nih.gov/pubmed/34779707 http://dx.doi.org/10.1080/0886022X.2021.2000875 |